The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury

Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix (ECM) molecules that are widely expressed throughout the developing and adult CNS. In vitro studies demonstrate their potential to restrict neurite outgrowth, and it is believed that CSPGs also inhibit axonal regeneration after CNS injury in vivo. Previous studies demonstrated that CSPGs are generally upregulated after spinal cord injury, and more recent reports have begun to identify individual proteoglycans that may play dominant roles in limiting axonal regeneration. The current study systematically examined the extended deposition patterns after CNS injury of four putatively inhibitory CSPGs that have not been extensively investigated previously in vivo: neurocan, brevican, phosphacan, and versican. After spinal cord injury, neurocan, brevican, and versican immunolabeling increased within days in injured spinal cord parenchyma surrounding the lesion site and peaked at 2 weeks. Neurocan and versican were persistently elevated for 4 weeks postinjury, and brevican expression persisted for at least 2 months. On the other hand, phosphacan immunolabeling decreased in the same region immediately following injury but later recovered and then peaked after 2 months. Combined glial fibrillary acidic protein (GFAP) immunohistochemistry and in situ hybridization demonstrated that GFAP astrocytes constituted a source of neurocan production after spinal cord injury. Thus, the production of several CSPG family members is differentially affected by spinal cord injury, overall establishing a CSPG-rich matrix that persists for up to 2 months following injury. Optimization of strategies to reduce CSPG expression to enhance regeneration may need to target several different family members over an extended period following injury.

[1]  J. Prince,et al.  The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.

[2]  S. R. Thornton,et al.  Comparing Astrocytic Cell Lines that Are Inhibitory or Permissive for Axon Growth: the Major Axon-Inhibitory Proteoglycan Is NG2 , 1999, The Journal of Neuroscience.

[3]  N. D. Mar,et al.  UP-REGULATION OF A KERATAN SULFATE PROTEOGLYCAN FOLLOWING CORTICAL INJURY IN NEONATAL RATS , 1996, International Journal of Developmental Neuroscience.

[4]  J. Levine,et al.  A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus , 1999, Neuroscience.

[5]  E. Powell,et al.  Dissection of astrocyte‐mediated cues in neuronal guidance and process extension , 1999, Glia.

[6]  V. Perry,et al.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord , 1999, The European journal of neuroscience.

[7]  B. Stokes,et al.  Proliferation of NG2-Positive Cells and Altered Oligodendrocyte Numbers in the Contused Rat Spinal Cord , 2001, The Journal of Neuroscience.

[8]  P. Anderson,et al.  Correlation between Putative Inhibitory Molecules at the Dorsal Root Entry Zone and Failure of Dorsal Root Axonal Regeneration , 2001, Molecular and Cellular Neuroscience.

[9]  Weiquan Lu,et al.  The Tissue Plasminogen Activator (Tpa/Plasmin) Extracellular Proteolytic System Regulates Seizure-Induced Hippocampal Mossy Fiber Outgrowth through a Proteoglycan Substrate , 2000, The Journal of cell biology.

[10]  R. Armstrong,et al.  In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. , 1998, Journal of neurobiology.

[11]  J. Fawcett,et al.  Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC , 2001, Nature Neuroscience.

[12]  A. Nishiyama,et al.  Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion , 2001, Glia.

[13]  J. Levine.  Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  D. Friedlander,et al.  Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules , 1994, The Journal of cell biology.

[15]  J. Fawcett,et al.  Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat , 2002, Neuroscience.

[16]  J. Levine,et al.  Multiple Regions of the NG2 Proteoglycan Inhibit Neurite Growth and Induce Growth Cone Collapse , 2003, The Journal of Neuroscience.

[17]  M. Tuszynski,et al.  Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Fawcett,et al.  Versican Is Upregulated in CNS Injury and Is a Product of Oligodendrocyte Lineage Cells , 2002, The Journal of Neuroscience.

[19]  Y. Yamaguchi.  Chondroitin Sulfate Proteoglycans in the Nervous System , 2000 .

[20]  F. Gage,et al.  Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury , 1997, The Journal of Neuroscience.

[21]  Mark H. Tuszynski,et al.  NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.

[22]  C. Haas,et al.  Entorhinal Cortex Lesion in Adult Rats Induces the Expression of the Neuronal Chondroitin Sulfate Proteoglycan Neurocan in Reactive Astrocytes , 1999, The Journal of Neuroscience.

[23]  M. Frotscher,et al.  The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats , 2000, The European journal of neuroscience.

[24]  Douglas K. Anderson,et al.  Intact Aggrecan and Fragments Generated by Both Aggrecanse and Metalloproteinase-Like Activities Are Present in the Developing and Adult Rat Spinal Cord and Their Relative Abundance Is Altered by Injury , 2001, The Journal of Neuroscience.

[25]  Stacey P. Memberg,et al.  Regeneration of adult axons in white matter tracts of the central nervous system , 1997, Nature.

[26]  G. Plant,et al.  Inhibitory Proteoglycan Immunoreactivity Is Higher at the Caudal Than the Rostral Schwann Cell Graft-Transected Spinal Cord Interface , 2001, Molecular and Cellular Neuroscience.

[27]  Kazuki Hagihara,et al.  The Brain Chondroitin Sulfate Proteoglycan Brevican Associates with Astrocytes Ensheathing Cerebellar Glomeruli and Inhibits Neurite Outgrowth from Granule Neurons , 1997, The Journal of Neuroscience.

[28]  J. Fawcett,et al.  Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes , 2000, The Journal of Neuroscience.

[29]  V. Perry,et al.  Cytokine-induced acute inflammation in the brain and spinal cord. , 1999, Journal of neuropathology and experimental neurology.

[30]  J. Levine,et al.  Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  E. Geisert,et al.  A CNS specific proteoglycan associated with astrocytes in rat optic nerve , 1992, Brain Research.

[32]  M. Schachner,et al.  Functional Involvement of Sciatic Nerve‐derived Versicanand Decorin‐like Molecules and other Chondroitin Sulphate Proteoglycans in ECM‐mediated Cell Adhesion and Neurite Outgrowth , 1995, The European journal of neuroscience.

[33]  C. Bandtlow,et al.  Brain derived versican V2 is a potent inhibitor of axonal growth. , 2000, Journal of cell science.

[34]  James W. Fawcett,et al.  Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.

[35]  S. Hockfield,et al.  Intracranial Injury Acutely Induces the Expression of the Secreted Isoform of the CNS-Specific Hyaluronan-Binding Protein BEHAB/Brevican , 1999, Experimental Neurology.

[36]  M. Bähr,et al.  Immunocytochemical characterization of reactive optic nerve astrocytes and meningeal cells , 1999, Glia.

[37]  Douglas K. Anderson,et al.  Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation , 1999, Experimental Neurology.

[38]  J. Levine,et al.  Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord , 1998, Glia.

[39]  J. Verhaagen,et al.  Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A , 2001, The European journal of neuroscience.

[40]  B. Stokes,et al.  Cytokine mRNA Profiles in Contused Spinal Cord and Axotomized Facial Nucleus Suggest a Beneficial Role for Inflammation and Gliosis , 1998, Experimental Neurology.

[41]  M. Jurynec,et al.  The Chondroitin Sulfate Proteoglycans Neurocan and Phosphacan Are Expressed by Reactive Astrocytes in the Chronic CNS Glial Scar , 1999, The Journal of Neuroscience.

[42]  P. Maurel,et al.  Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jerry Silver,et al.  Activated Macrophages and the Blood–Brain Barrier: Inflammation after CNS Injury Leads to Increases in Putative Inhibitory Molecules , 1997, Experimental Neurology.

[44]  H. Müller,et al.  Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons , 1999, Neuroscience.

[45]  M. Tuszynski,et al.  Spinal Cord Injury Elicits Expression of Keratan Sulfate Proteoglycans by Macrophages, Reactive Microglia, and Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.